metricas
covid
Annals of Hepatology Most cited
Journal Information

Most cited

Data available in articles published since the year 2014

479
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group
Ann Hepatol. 2024;29:101133
479
Full text access
50
Alcohol-associated liver disease: Epidemiology and management
Helena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller
Ann Hepatol. 2024;29:101162
50
Full text access
33
Alcohol-related liver disease: A global perspective
Graciela Elia Castro Narro, Luis Antonio Díaz, Eric Kauffman Ortega, María Fernanda Bautista Garín, Eira Cerda Reyes, Pindaro Sebastian Martinez Delfin, Juan Pablo Arab, Ramón Bataller
Ann Hepatol. 2024;29:101499
33
Full text access
28
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease
Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam
Ann Hepatol. 2024;29:101512
28
Full text access
26
From NAFLD to MASLD: When metabolic comorbidity matters
Shan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei
Ann Hepatol. 2024;29:101281
26
Full text access
25
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Shudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
25
Full text access
23
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, Varenka J Barbero-Becerra
Ann Hepatol. 2024;29:101182
23
Full text access
18
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis
Wasit Wongtrakul, Natthinee Charatcharoenwitthaya, Phunchai Charatcharoenwitthaya
Ann Hepatol. 2024;29:101288
18
Full text access
18
Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Adnan Malik, Sadia Javaid, Muhammad Imran Malik, Shahbaz Qureshi
Ann Hepatol. 2024;29:101544
18
Full text access
17
Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database
Mary Nemer, Fauzia Osman, Adnan Said
Ann Hepatol. 2024;29:101491
17
Full text access